(E,E)-pentadeca-5,7-diene-9,11,13-triyn-2-one - Compound Card

(E,E)-pentadeca-5,7-diene-9,11,13-triyn-2-one

Select a section from the left sidebar

(E,E)-pentadeca-5,7-diene-9,11,13-triyn-2-one

Structure
Zoomed Structure
  • Family: Plantae - Apiaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Polyacetylene
Canonical Smiles CC#CC#CC#C/C=C/C=C/CCC(=O)C
InChI InChI=1S/C15H14O/c1-3-4-5-6-7-8-9-10-11-12-13-14-15(2)16/h9-12H,13-14H2,1-2H3/b10-9+,12-11+
InChIKey MKNPSCYLXYXFEY-HULFFUFUSA-N
Formula C15H14O
HBA 1
HBD 0
MW 210.28
Rotatable Bonds 4
TPSA 17.07
LogP 2.5
Number Rings 0
Number Aromatic Rings 0
Heavy Atom Count 16
Formal Charge 0
Fraction CSP3 0.27
Exact Mass 210.1
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Bupleurum spinosum Apiaceae Plantae 199135

Showing of synonyms

  • Barrero AF, Ali Haídour A, et al. (1998). Polyacetylenes, terpenoids and flavonoids from Bupleurum spinosum. Phytochemistry,1998,48(7),1237-1240. [View]
Pubchem: 101415749
Nmrshiftdb2: 60051402

No compound-protein relationship available.

No scaffolds available.

No bioactivities available.

Absorption

Caco-2 (logPapp)
-3.84
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.34
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.43

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
1.11
Plasma Protein Binding
45.35
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Inhibitor
CYP 2C9 Substrate
Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
9.7
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
1.58
Biodegradation
Toxic
Carcinogenesis
Toxic
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Toxic
Eye Irritation
Toxic
Maximum Tolerated Dose
0.6
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
5.82
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Toxic
T. Pyriformis
8.29
Rat (Acute)
2.3
Rat (Chronic Oral)
1.72
Fathead Minnow
5.03
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Toxic
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
322.04
Hydration Free Energy
-2.48
Log(D) at pH=7.4
3.34
Log(P)
4.63
Log S
-3.87
Log(Vapor Pressure)
-3.61
Melting Point
87.12
pKa Acid
10.78
pKa Basic
3.88
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Sodium/potassium-transporting ATPase subunit alpha Q4H132 Q4H132_SQUAC Squalus acanthias 2 0.7798
Sodium/potassium-transporting ATPase subunit alpha Q4H132 Q4H132_SQUAC Squalus acanthias 2 0.7798
thiamine diphosphokinase Q82ZE3 Q82ZE3_ENTFA Enterococcus faecalis 2 0.7207
thiamine diphosphokinase Q82ZE3 Q82ZE3_ENTFA Enterococcus faecalis 2 0.7207

Download SDF